487 related articles for article (PubMed ID: 26460101)
1. Effective Treatment with Intravitreal Injection of Bevacizumab for Exudative Retinal Detachment Secondary to Choroidal Metastasis of Non-Small Cell Lung Carcinoma.
Yasui H; Sato K; Takeyama Y; Nishihara H; Maeda M; Gonda H; Suzuki R
Am J Case Rep; 2015 Oct; 16():728-32. PubMed ID: 26460101
[TBL] [Abstract][Full Text] [Related]
2. EXUDATIVE RETINAL DETACHMENT CAUSED BY A CHOROIDAL NEOVASCULAR MEMBRANE IN HALLERMANN-STREIFF SYNDROME.
AlAli A; Bourgault S; Clark I; Lam WC
Retin Cases Brief Rep; 2018 Winter; 12(1):45-47. PubMed ID: 27648586
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal Bevacizumab for Traumatic Choroidal Rupture.
Kim M; Kim JH; Seo Y; Koh HJ; Lee SC
Optom Vis Sci; 2015 Oct; 92(10):e363-7. PubMed ID: 26367340
[TBL] [Abstract][Full Text] [Related]
4. Exudative Retinal Detachment Reveals Metastatic Bladder Cancer.
Di Mattina AJ; Fazelat A; Santaro A
Optom Vis Sci; 2016 May; 93(5):549-54. PubMed ID: 26855241
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal bevacizumab in the management of subretinal fluid associated with choroidal osteoma.
Song JH; Bae JH; Rho MI; Lee SC
Retina; 2010 Jun; 30(6):945-51. PubMed ID: 20531145
[TBL] [Abstract][Full Text] [Related]
6. Rebound inflammation after an intravitreal injection in Vogt-Koyanagi-Harada syndrome.
Ranjan R; Agarwal M
Indian J Ophthalmol; 2018 Jun; 66(6):863-865. PubMed ID: 29786006
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal triamcinolone versus intravitreal bevacizumab in the treatment of exudative retinal detachment secondary to posterior uveal melanoma.
Parrozzani R; Pilotto E; Dario A; Miglionico G; Midena E
Am J Ophthalmol; 2013 Jan; 155(1):127-133.e2. PubMed ID: 22995029
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal bevacizumab for consecutive multiple choroidal breast metastatic lesions.
Mansour AM; Alameddine R
BMJ Case Rep; 2012 Jun; 2012():. PubMed ID: 22707687
[TBL] [Abstract][Full Text] [Related]
9. Rescue therapy with intravitreal aflibercept for choroidal neovascularization secondary to choroidal osteoma non-responder to intravitreal bevacizumab and ranibizumab.
Saitta A; Nicolai M; Neri P; Reibaldi M; Giovannini A; Mariotti C
Int Ophthalmol; 2015 Jun; 35(3):441-4. PubMed ID: 25761547
[TBL] [Abstract][Full Text] [Related]
10. Treatment of ocular metastasis with anti-VEGF: a literature review and case report.
Augustine H; Munro M; Adatia F; Webster M; Fielden M
Can J Ophthalmol; 2014 Oct; 49(5):458-63. PubMed ID: 25284103
[TBL] [Abstract][Full Text] [Related]
11. The effect of intravitreal bevacizumab and transpupillary thermotherapy on choroidal metastases and literature review.
Lin CJ; Tsai YY
Indian J Ophthalmol; 2015 Jan; 63(1):37-41. PubMed ID: 25686061
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of three intravitreal injections of bevacizumab in the treatment of exudative age-related macular degeneration].
Bidot ML; Malvitte L; Bidot S; Bron A; Creuzot-Garcher C
J Fr Ophtalmol; 2011 Jun; 34(6):376-81. PubMed ID: 21550687
[TBL] [Abstract][Full Text] [Related]
13. Complete regression of choroidal metastasis secondary to non-small-cell lung cancer with intravitreal bevacizumab and oral erlotinib combination therapy.
Kim SW; Kim MJ; Huh K; Oh J
Ophthalmologica; 2009; 223(6):411-3. PubMed ID: 19628953
[TBL] [Abstract][Full Text] [Related]
14. Systemic bevacizumab (Avastin) for exudative retinal detachment secondary to choroidal melanoma.
Newman H; Finger PT; Chin KJ; Pavlick AC
Eur J Ophthalmol; 2011; 21(6):796-801. PubMed ID: 21445839
[TBL] [Abstract][Full Text] [Related]
15. Treatment of serous macular detachment associated with circumscribed choroidal hemangioma.
Kwon HJ; Kim M; Lee CS; Lee SC
Am J Ophthalmol; 2012 Jul; 154(1):137-145.e1. PubMed ID: 22465363
[TBL] [Abstract][Full Text] [Related]
16. A Surgical Technique for the Management of Tractional Retinal Detachment in Aggressive Posterior Retinopathy of Prematurity Treated With Intravitreal Bevacizumab.
De la Huerta I; Yonekawa Y; Thomas BJ; Capone A
Retina; 2019 Oct; 39 Suppl 1():S156-S159. PubMed ID: 30198966
[No Abstract] [Full Text] [Related]
17. Intravitreal bevacizumab in the successful management of choroidal metastases secondary to lung and breast cancer unresponsive to systemic therapy: a case series.
Fenicia V; Abdolrahimzadeh S; Mannino G; Verrilli S; Balestrieri M; Recupero SM
Eye (Lond); 2014 Jul; 28(7):888-91. PubMed ID: 24763241
[TBL] [Abstract][Full Text] [Related]
18. Failure of intravitreal bevacizumab in the treatment of choroidal metastasis.
Maudgil A; Sears KS; Rundle PA; Rennie IG; Salvi SM
Eye (Lond); 2015 May; 29(5):707-11. PubMed ID: 25771814
[TBL] [Abstract][Full Text] [Related]
19. Regression of serous macular detachment due to peripheral exudative hemorrhagic chorioretinopathy following intravitreal bevacizumab.
Barkmeier AJ; Kadikoy H; Holz ER; Carvounis PE
Eur J Ophthalmol; 2011; 21(4):506-8. PubMed ID: 21240857
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal bevacizumab (avastin) for circumscribed choroidal hemangioma.
Mandal S; Naithani P; Venkatesh P; Garg S
Indian J Ophthalmol; 2011; 59(3):248-51. PubMed ID: 21586854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
